Cart
sales@molnova.com
Parethoxycaine hydrochloride
CAS No. 136-46-9
Parethoxycaine hydrochloride( 2-(diethylamino)ethyl 4-ethoxybenzoate hydrochloride | Diethoxin )
Catalog No. M28658 CAS No. 136-46-9
Parethoxycaine hydrochloride is an anesthetic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 187 | In Stock |
|
| 5MG | 192 | In Stock |
|
| 10MG | 281 | In Stock |
|
| 25MG | 449 | In Stock |
|
| 50MG | 625 | In Stock |
|
| 100MG | 830 | In Stock |
|
| 200MG | 1097 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameParethoxycaine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionParethoxycaine hydrochloride is an anesthetic.
-
DescriptionParethoxycaine hydrochloride is an anesthetic.
-
In Vitro——
-
In Vivo——
-
Synonyms2-(diethylamino)ethyl 4-ethoxybenzoate hydrochloride | Diethoxin
-
PathwayOthers
-
TargetOther Targets
-
RecptorTyrosine phosphatase|c-Src
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number136-46-9
-
Formula Weight301.81
-
Molecular FormulaC15H24ClNO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCN(CC)CCOC(c(cc1)ccc1OCC)=O.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ku B, et al. Identification of N-(5-(phenoxymethyl)-1,3,4-thiadiazol-2-yl)acetamide derivatives as novel protein tyrosine phosphatase epsilon inhibitors exhibiting anti-osteoclastic activity. ioorg Med Chem. 2018 Oct 1;26(18):5204-5211.
molnova catalog
related products
-
BAY 73-1449
BAY 73-1449 is a selective and potent antagonist of the prostacyclin receptor(IC50<0.1 nM).
-
S107
S107 is a RyR-selective 1, 4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.
-
p-Coumaric Acid Ethy...
p-Coumaric Acid Ethyl Ester is the ethyl ester of p-Coumaric acid. p-Coumaric Acid is a potential immunosuppressive agent in treating autoimmune inflammatory diseases like rheumatoid arthritis.
